|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of May 20, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Current assets | |||||||||||||||
| Cash | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Accounts receivable | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Related Party | |||||||||||||||
| Inventories, net | |||||||||||||||
| Prepaid expenses | |||||||||||||||
| Other receivable | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Related Party | |||||||||||||||
| Advance to supplier | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Related Party | |||||||||||||||
| Prepayment - related party (current) | |||||||||||||||
| Deferred offering cost | |||||||||||||||
| Promissory note receivable | |||||||||||||||
| Note receivable | |||||||||||||||
| Total current assets | |||||||||||||||
| Marketable securities held in the trust account | |||||||||||||||
| Trust escrow account | |||||||||||||||
| Right-of-use asset | |||||||||||||||
| Other non-current assets | |||||||||||||||
| Prepayment - related party | |||||||||||||||
| Long-term investment | |||||||||||||||
| TOTAL ASSETS | |||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||||||
| Current liabilities | |||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||
| Accrued underwriting discount | |||||||||||||||
| Due to related party | |||||||||||||||
| Related Party | |||||||||||||||
| Total due to related party | |||||||||||||||
| Promissory notes | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Related Party | |||||||||||||||
| Third Party | |||||||||||||||
| Total promissory notes | |||||||||||||||
| Accounts payable | |||||||||||||||
| Accrued and other liabilities | |||||||||||||||
| Tax payable | |||||||||||||||
| Other payable | |||||||||||||||
| Short term bank loan | |||||||||||||||
| Lease liability - current | |||||||||||||||
| Warranty liabilities - current | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Lease liability - noncurrent | |||||||||||||||
| Warranty liabilities - noncurrent | |||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||
| Ordinary shares subject to possible redemption (1,574,356 shares at $12.02 and $11.47 per share as of September 30, 2025 and December 31, 2024, respectively) | |||||||||||||||
| Stockholders’ equity | |||||||||||||||
| Common stock, $0.0001 par value, 100,000,000 shares authorized, 22,600,363 and 22,595,363 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
Loading...
